Hints and tips:
...Cazenove saw US peer Biomet as the only likely trade buyer. However. Biomet was taken private at the top of the market and is burdened with too much debt, the broker said....
...A deal for Biomet would create an orthopaedic specialist worth up to $20bn and capable of competing against the US sector leaders, Zimmer and Stryker....
...Smith & Nephew, the medical devices maker added 2.3 per cent to 531p as investors read across upbeat results from its rivals in the orthopaedics market, Biomet, Stryker and Zimmer....
International Edition